AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE1090.30-2.7 (-0.25 %)
PREV CLOSE ( ) 1093.00
OPEN PRICE ( ) 1099.70
BID PRICE (QTY) 1090.15 (23)
OFFER PRICE (QTY) 1091.40 (2)
VOLUME 1867
TODAY'S LOW / HIGH ( )1087.00 1099.70
52 WK LOW / HIGH ( )581.5 1177
NSE1090.20-3.05 (-0.28 %)
PREV CLOSE( ) 1093.25
OPEN PRICE ( ) 1095.20
BID PRICE (QTY) 1089.85 (2)
OFFER PRICE (QTY) 1090.20 (11)
VOLUME 74144
TODAY'S LOW / HIGH( ) 1087.15 1097.00
52 WK LOW / HIGH ( )581.25 1177.1
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.